Rapid MEN 2A gene carrier identification using primer-specific PCR amplification

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 59, Issue 8, 1999, Pages 643-647

  Kroustrup, J P ^a   Laurberg, P ^b   Madsen, P H ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

Genetic test; MEN 2A; PCR technique

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIPPLE SYNDROME;

EID: 0033389344     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519950185148     Document Type: Article

References (11)

1. 1 Sipple JH. The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 1961; 31: 163-6.
2. 2 Donnis-Keller H, Dou S, Chi D, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993; 2: 851-6.
3. 3 Mulligan LM, Kwok JBJ, Healy CS, et al. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-60.
4. 4 Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia Type 2. International RET mutation consortium analysis. JAMA 1996; 276: 1575-9.
5. 5 Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation systems (ARMS). Nucleic Acids Res 1989; 17: 2503-16.
6. 6 Ballabic A, Gibbs RA, Caskey CT. PCR test for cystic fibrosis deletion. Nature 1990; 343: 220.
7. 7 Krarup H, Drewes A, Madsen PH. Quantitative HCV-PCR. Scand J Clin Lab Invest 1998; 58: 415-22.
8. 8 Gagel RF, Cote GJ, Martins Bugalho MJG, et al. Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. J Intern Med 1995; 238: 333-41.
9. 9 Thakker RV, Ponder BAJ. Multiple endocrine neoplasia. Syndromes of the twentieth century. J Clin Endocrinol Metab 1998; 83: 2617-20.
10. 10 Lips CJM, Landsvater RM, Höppener JWM, et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia. N Engl J Med 1994; 331: 828-35.
11. 11 Wohllk N, Cote GJ, Evans BE, Goepfert H, Ordonez G, Gagel GF. Application of genetic information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocrinol Metab Clin North Am 1996; 25: 1-25.